HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies.
Coyle D, Durand-Zaleski I, Farrington J, Garrison L, Graf von der Schulenburg J-M, Greiner W, Longworth L, Meunier A, Moutie A-S, Palmer S, Pemberton-Whiteley Z, et al. (2020)
The European journal of health economics : HEPAC : health economics in prevention and care.